-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WFWkFfAUARXj/g7UHrbWwOtF5y4t3OveynoLjwf402uKoVslSTXP/YmMFrtzwAYF LsVlM1odjMAUHqvCVKpUrg== 0001181431-07-018320.txt : 20070309 0001181431-07-018320.hdr.sgml : 20070309 20070309184235 ACCESSION NUMBER: 0001181431-07-018320 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070307 FILED AS OF DATE: 20070309 DATE AS OF CHANGE: 20070309 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSCIENT PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0000356830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042297484 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 7813982300 MAIL ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: GENOME THERAPEUTICS CORP DATE OF NAME CHANGE: 19941215 FORMER COMPANY: FORMER CONFORMED NAME: COLLABORATIVE RESEARCH INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAUSCHER STEVEN M CENTRAL INDEX KEY: 0001166683 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10824 FILM NUMBER: 07685815 MAIL ADDRESS: STREET 1: C/O GNOME THERAPEUTICS CORP STREET 2: 100 BEAVER STREET CITY: WALTHAM STATE: MA ZIP: 02453 4 1 rrd150705.xml FORM 4 X0202 4 2007-03-07 0 0000356830 OSCIENT PHARMACEUTICALS CORP OSCI 0001166683 RAUSCHER STEVEN M 1000 WINTER ST. SUITE 2200 WALTHAM MA 02451 1 1 0 0 CEO and President Common Stock 2007-03-07 4 A 0 24196 0.00 A 39063 D Stock Option (right to purchase) 4.94 2007-03-07 4 A 0 60404 0.00 A 2017-03-06 Common Stock 60404 60404 D Restricted Shares issued under the Company's 2001 Incentive Plan; 50% vest on November 30, 2007 and 50% vest on November 30, 2008. Issued under the Company's 2001 Incentive Plan; vest quarterly in equal installments over 2 years from the date of grant. Joseph D. Vittiglio, Esq., Senior Corporate Attorney - Power of Attorney 2007-03-09 -----END PRIVACY-ENHANCED MESSAGE-----